ArticleFrontiers in pharmacology2022

Biomarkers of PEGylated Liposomal Doxorubicin-Induced Hypersensitivity Reaction in Breast Cancer Patients Based on Metabolomics.

Wei Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.